C85.1A
Unspecified B-cell lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified B-cell lymphoma in remission is a type of cancer that originates in the lymphatic system, specifically affecting B cells, which are a part of the immune system. When diagnosed as 'in remission,' it means that the signs and symptoms of the disease are reduced or have disappeared following treatment. This condition, coded as C85.1A in the ICD-10 classification, highlights a stage where monitoring is essential to ensure the lymphoma does not return. Understanding this diagnosis can help patients and their loved ones better navigate the journey of treatment and follow-up care.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting B-cell growth and development Exposure to certain chemicals or radiation Immunodeficiency conditions that weaken the immune system Previous history of other lymphomas or cancers Age-related changes in immune function
Key Symptoms: Swelling or lumps in the lymph nodes, often painless Unexplained weight loss Persistent fatigue or weakness Fever that comes and goes Night sweats Unintended loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical examinations, imaging tests, and laboratory procedures. A biopsy of the lymphatic tissue provides definitive confirmation of lymphoma. Once diagnosed, staging tests determine the extent of the disease. During remission, regular follow-up appointments, imaging studies, and blood tests are essential to monitor for any signs of recurrence.
Treatment Protocols: Chemotherapy: Use of drugs to destroy cancerous B cells Immunotherapy: Boosting the immune system's ability to fight lymphoma Radiation therapy: Targeted radiation to eliminate remaining cancer cells Targeted therapy: Drugs designed to attack specific molecules involved in cancer growth Stem cell or bone marrow transplants: For some cases, to restore healthy blood cell production
Clinical Advice & FAQs
Billing Guidance
Is C85.1A a billable ICD-10 code?
Yes, C85.1A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.1A?
Clinical documentation must specify the nature of Unspecified B-cell lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference